Research project

An open, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (PolaRICE) with rituximab, ifosfamide, carboplatin and etoposide (RICE)

Staff

Lead researchers

Professor Andy Davies BSc (Hons) BM (Hons) PhD FRCP

Professor of Haematological Oncology
Connect with Andy

Other researchers

Professor Gareth Griffiths

Director SCTU & Prof of Clinical Trials
Research interests
  • Gareth Griffiths is Professor of Clinical Trials and directs our Southampton Clinical Trials …
  • His works spans the different phases of clinical trials, from small dose finding and safety s…
  • Phase I-III clinical trials
Connect with Gareth

Collaborating research institutes, centres and groups

Research outputs